KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Net Cash Flow: 2009-2024

Historic Net Cash Flow for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $123.5 million.

  • Pacira BioSciences' Net Cash Flow fell 13965.07% to -$153.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.7 million, marking a year-over-year decrease of 167.22%. This contributed to the annual value of $123.5 million for FY2024, which is 151.18% up from last year.
  • According to the latest figures from FY2024, Pacira BioSciences' Net Cash Flow is $123.5 million, which was up 151.18% from $49.2 million recorded in FY2023.
  • Pacira BioSciences' Net Cash Flow's 5-year high stood at $485.6 million during FY2021, with a 5-year trough of -$481.4 million in FY2022.
  • For the 3-year period, Pacira BioSciences' Net Cash Flow averaged around -$102.9 million, with its median value being $49.2 million (2023).
  • As far as peak fluctuations go, Pacira BioSciences' Net Cash Flow surged by 2,134.90% in 2021, and later tumbled by 199.14% in 2022.
  • Yearly analysis of 5 years shows Pacira BioSciences' Net Cash Flow stood at $21.7 million in 2020, then skyrocketed by 2,134.90% to $485.6 million in 2021, then slumped by 199.14% to -$481.4 million in 2022, then skyrocketed by 110.21% to $49.2 million in 2023, then soared by 151.18% to $123.5 million in 2024.